Publication

Article

Pharmacy Times

November 2013 Cough & Cold
Volume79
Issue 11

Yoga May Help Cancer Survivors Catch Quality Zzzs

New research suggests that yoga may help cancer survivors sleep more and sleep better after treatment.

New research published online on August 12, 2013, in the Journal of Clinical Oncology suggests that yoga may help cancer survivors sleep more and sleep better after treatment.

The study enrolled 410 cancer survivors who suffered from moderate to more severe sleep problems 2 to 24 months after they had been treated with surgery, chemotherapy, or radiation. Almost all patients were white women and 75% had had breast cancer. Participants were randomly assigned to receive standard care or standard care in addition to a 4-week yoga intervention. The yoga intervention used the Yoga for Cancer Survivors program, in which participants attended two, 75-minute sessions per week. Sleep quality was assessed both before and after the intervention using the Pittsburgh Sleep Quality Index questionnaire and actigraphy sensors worn at night.

Patients in both groups improved their sleep patterns, but the yoga group improved significantly more than the control group. Overall, patients who did yoga improved their general sleep quality by 2 points on average, while control-group patients improved on an average of 1.1 points. Those who did yoga also saw greater improvements in daytime sleepiness and the amount of time spent sleeping compared with those who did not do yoga.

The results also indicated that participants in the yoga group reduced their use of sleep aids by 21% per week, while participants in the control group increased their use of sleep aids by 5% each week.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com